RecruitingNot applicableNCT06753396

The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kutahya Health Sciences University
Principal Investigator
Berceste Güler Ayyıldız, Assoc. Prof. Dr
Kütahya Health Sciences University
Intervention
Platelet rich fibrin(procedure)
Enrollment
80 target
Eligibility
18 years · All sexes
Timeline
20222026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06753396 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials